Merck expands trials of tulisokibart to three new inflammatory diseases

2 hours ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Merck expands trials of tulisokibart to three new inflammatory diseases

Related

Citi stock holds Overweight rating at Piper Sandler amid Banamex sale

Citi stock holds Overweight rating at Piper Sandler amid Ban...

37 minutes ago 0
Piper Sandler reiterates Overweight rating on Brixmor Property stock

Piper Sandler reiterates Overweight rating on Brixmor Proper...

37 minutes ago 0
Beacon Rise enters agreement for £0.71 million chiropractor acquisition

Beacon Rise enters agreement for £0.71 million chiropractor ...

37 minutes ago 0

Trending

1. kroger recalls
2. wesley hunt
3. burj khalifa
4. donovan mitchell
5. texas a&m aggies football
6. frank bisignano
7. mitch albom
8. vz stock
9. paul tudor jones
10. dan schulman

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

8 months ago 578
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

6 months ago 342
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

9 months ago 259
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

7 months ago 249
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

7 months ago 221
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved